ACADIA Pharmaceuticals Inc.
ACAD NASDAQHealthcare ★★★★★Latest Earnings Above forecast↑
Date
Aug 4, 2026
ET
EPS Est.
0.07
EPS Actual
0.18
Revenue Est.
$296.6M
Revenue Actual
$308M
Next Earnings Report
Date
Nov 4, 2026 · Wed
Time
Your time zone matches ET
After-market(ET)
Fiscal Period
FY2026 Q3
EPS Est.
0.20
Revenue Est.
$332.3M
Company Overview
ACADIA Pharmaceuticals Inc. (ticker ACAD) is listed on NASDAQ with a market cap of about $5.05B. Its next earnings report (FY2026 Q3) is expected on Nov 4, 2026 (ET), After-market, with consensus EPS of 0.20. In the last 15 reported quarters, EPS beat consensus estimates 11 times.
Actual EPS TrendRecently15Term · Feb 27, 2023 → Aug 4, 2026
Feb 27, 2023Range: -0.40 ~ 1.60Aug 4, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 4, 2026 | -- | 0.07 | Above forecast↑0.18 | $296.6M | $308M |
| May 6, 2026 | -- | 0.04 | Below forecast↓0.02 | $280.3M | $268.1M |
| Feb 25, 2026 | -- | 0.14 | Above forecast↑1.60 | $292.8M | $284M |
| Nov 5, 2025 | -- | 0.14 | Above forecast↑0.42 | $276.5M | $278.6M |
| Aug 6, 2025 | -- | 0.14 | 0.16 | $262M | $264.6M |
| May 7, 2025 | -- | 0.10 | 0.11 | $239M | $244.3M |
| Feb 26, 2025 | -- | 0.19 | Above forecast↑0.86 | $255.6M | $259.6M |
| Nov 6, 2024 | -- | 0.14 | Above forecast↑0.20 | $282.9M | $250.4M |
| Aug 6, 2024 | -- | 0.18 | 0.20 | $235.4M | $242M |
| May 8, 2024 | -- | 0.05 | Above forecast↑0.10 | $208.3M | $205.8M |
| Feb 27, 2024 | -- | 0.30 | 0.28 | $223.8M | $231M |
| Nov 2, 2023 | -- | -0.43 | -0.40 | $224.4M | $211.7M |
| Aug 2, 2023 | -- | -0.12 | Above forecast↑0.01 | $157.9M | $165.2M |
| May 8, 2023 | -- | -0.21 | Below forecast↓-0.27 | $120.1M | $118.5M |
| Feb 27, 2023 | -- | -0.25 | -0.26 | $134.2M | $136.5M |
Original Filings (SEC)
Quarterly10-Q · 2026-08-05 ↗
Earnings Release8-K · 2026-08-04 ↗
Quarterly10-Q · 2026-05-07 ↗
Earnings Release8-K · 2026-05-06 ↗
Annual10-K · 2026-02-26 ↗
Earnings Release8-K · 2026-02-25 ↗
Quarterly10-Q · 2025-11-06 ↗
Earnings Release8-K · 2025-11-05 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
